Growth Metrics

Cumberland Pharmaceuticals (CPIX) Change in Receivables (2016 - 2026)

Cumberland Pharmaceuticals' Change in Receivables history spans 16 years, with the latest figure at $6.5 million for Q4 2025.

  • On a quarterly basis, Change in Receivables rose 1566.71% to $6.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $5.2 million, a 169.82% increase, with the full-year FY2025 number at $5.2 million, up 169.82% from a year prior.
  • Change in Receivables hit $6.5 million in Q4 2025 for Cumberland Pharmaceuticals, up from $113691.0 in the prior quarter.
  • Over the last five years, Change in Receivables for CPIX hit a ceiling of $7.8 million in Q1 2022 and a floor of -$3.4 million in Q2 2021.
  • Historically, Change in Receivables has averaged $219846.4 across 5 years, with a median of -$58225.0 in 2023.
  • Biggest five-year swings in Change in Receivables: surged 4421.45% in 2022 and later crashed 666.56% in 2024.
  • Tracing CPIX's Change in Receivables over 5 years: stood at -$3.0 million in 2021, then soared by 30.41% to -$2.1 million in 2022, then decreased by 21.54% to -$2.5 million in 2023, then skyrocketed by 115.54% to $390841.0 in 2024, then soared by 1566.71% to $6.5 million in 2025.
  • Business Quant data shows Change in Receivables for CPIX at $6.5 million in Q4 2025, $113691.0 in Q3 2025, and -$171014.0 in Q2 2025.